Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02456039
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
DM8 | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 276D | 0.84 | |
DM8 | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 288D | 0.84 | |
DM8 | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 277D | 0.84 | |
DM8 | 2'-BROMO-4'-EPIDAUNORUBICIN | A,B | 380D | 0.84 | |
DM8 | 2'-BROMO-4'-EPIDAUNORUBICIN | A,B | 381D | 0.84 | |
DM8 | 2'-BROMO-4'-EPIDAUNORUBICIN | A | 278D | 0.84 | |
MUS | 4-METHYL-2-OXO-2H-CHROMEN-7-YL 5- (ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO- NON-2-ULOPYRANOSIDONIC ACID | A | 1S0J | 0.73 | |
DM4 | 1-O-DEMETHYL-6-DEOXYDOXORUBICIN | A | 1D37 | 0.84 | |
ERT | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW2 | 0.85 | |
ERT | METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY- 7-METHOXY-6,11-DIOXO-4-{[2,3,6- TRIDEOXY-3-(DIMETHYLAMINO)-BETA- D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H- TETRACENE-1-CARBOXYLATE | A,B | 1TW3 | 0.85 | |
C39 | N-[(2S,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-7-METHYL-2-(1-METHYLETHYL)- 8-OXOOCTYL]-2-(3-METHOXYPROPOXY)BENZAMIDE | C,O | 2V12 | 0.72 | |
DZN | DAIDZIN | A,B,C,D,E,F, G,H | 2VLE | 0.71 | |
B8L | 3-[(3-SEC-BUTYL-4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-(2-HYDROXY-5-METHOXYBENZOYL)BENZOATE | A | 1REK | 0.77 | |
AKA | 10-DECARBOXYMETHYLACLACINOMYCIN A (DCMAA) | A | 1Q0Z | 0.81 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 215D | 0.85 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 235D | 0.85 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A | 234D | 0.85 | |
DMM | 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)- DOXORUBICIN | A,B | 2DES | 0.85 | |
44D | 7-[5-(4-AMINO-5-HYDROXY-6-METHYL- TETRAHYDRO-PYRAN-2-YLOXY)-4-HYDROXY- 6-METHYL-TETRAHYDRO-PYRAN-2-YLOXY]- 6,9,11-TRIHYDROXY-9-(2-HYDROXY- ACETYL)-7,8,9,10-TETRAHYDRO-NAPHTHACENE- 5,12-DIONE | A,B | 1NAB | 0.83 | |
TAC | TETRACYCLINE | A,B,C,D,E,F, G,H,I,J,K,L | 2HDN | 0.7 | |
TAC | TETRACYCLINE | A | 2VKE | 0.7 | |
TAC | TETRACYCLINE | A | 2TRT | 0.7 | |
TAC | TETRACYCLINE | B | 2UXO | 0.7 | |
TAC | TETRACYCLINE | A,B,D,E,G,H, J,K,L,N,P,Q, R,T | 1I97 | 0.7 | |
TAC | TETRACYCLINE | A,D,H,N | 1HNW | 0.7 | |
TAC | TETRACYCLINE | A,B | 2HCJ | 0.7 | |
485 | [2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (3,4,5-TRIHYDROXY-6-METHYL-TETRAHYDRO- PYRAN-2-YL)- ACETIC ACID | A | 1JIL | 0.72 | |
941 | 2-(4-{2-TERT-BUTOXYCARBONYLAMINO- 2-[4-(3-HYDROXY-2-METHOXYCARBONYL- PHENOXY)-BUTYLCARBAMOYL]-ETHYL}- PHENOXY)-MALONIC ACID | A | 1PYN | 0.71 | |
DXT | (4S,4AR,5S,5AR,6R,12AS)-4-(DIMETHYLAMINO)- 3,5,10,12,12A-PENTAHYDROXY-6-METHYL- 1,11-DIOXO-1,4,4A,5,5A,6,11,12A- OCTAHYDROTETRACENE-2-CARBOXAMIDE | A | 2O7O | 0.72 | |
CHR | NEOCARZINOSTATIN-CHROMOPHORE | A | 1O5P | 0.78 | |
CHR | NEOCARZINOSTATIN-CHROMOPHORE | A,B | 1NCO | 0.78 | |
BD2 | 3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN- 4-YL 4-(2-HYDROXYBENZOYL)BENZOATE | A | 1RE8 | 0.72 | |
DBO | N-{(1S,2R)-1-BENZYL-2-HYDROXY-3- [(3-METHYLBENZYL)AMINO]PROPYL}DIBENZO[B,F]OXEPINE- 10-CARBOXAMIDE | A,B,C,D | 2EWY | 0.7 | |
CS9 | N'-{(1S,2R)-1-(3,5-DIFLUOROBENZYL)- 2-HYDROXY-2-[(2R,4R)-4-PHENOXYPYRROLIDIN- 2-YL]ETHYL}-5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE | A,B | 2QMF | 0.7 | |
DM1 | DAUNOMYCIN | A | 152D | 0.87 | |
DM1 | DAUNOMYCIN | A,B,C,D | 1O0K | 0.87 | |
DM1 | DAUNOMYCIN | A | 1JO2 | 0.87 | |
DM1 | DAUNOMYCIN | A,B | 308D | 0.87 | |
DM1 | DAUNOMYCIN | A | 1D33 | 0.87 | |
DM1 | DAUNOMYCIN | A | 110D | 0.87 | |
DM1 | DAUNOMYCIN | A | 1D11 | 0.87 | |
DM1 | DAUNOMYCIN | A | 427D | 0.87 | |
DM1 | DAUNOMYCIN | A | 2D34 | 0.87 | |
DM1 | DAUNOMYCIN | A | 3F8F | 0.87 | |
DM1 | DAUNOMYCIN | A | 1D10 | 0.87 | |
DM1 | DAUNOMYCIN | A | 1DA0 | 0.87 | |
NOD | N-ETHYLHYDROXY-DOXORUBICIN | A | 385D | 0.89 | |
DM9 | N-HYDROXYMETHYL-N-(2-METHOXYETHYL)- DAUNOMYCIN | A | 482D | 0.79 | |
NGP | NOGALAMYCIN (PROTONATED FORM) | A | 1L0R | 0.82 | |
FLQ | N-[6-(ACETYLAMINO)HEXYL]-3',6'- DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN- 1,9'-XANTHENE]-6-CARBOXAMIDE | C | 2FDC | 0.73 | |
MNG | MENOGARIL | A,B | 202D | 0.85 | |
CS5 | N'-{(1S,2R)-1-(3,5-DIFLUOROBENZYL)- 2-HYDROXY-3-[(3-METHOXYBENZYL)AMINO]PROPYL}- 5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE | A,B | 2QK5 | 0.72 | |
NCG | A | 1MP7 | 0.76 | ||
DBL | DEGLUCOBALHIMYCIN | A,B,C,P | 1HHZ | 0.72 | |
DBL | DEGLUCOBALHIMYCIN | A,B,N,P | 1HHY | 0.72 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D15 | 0.87 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D54 | 0.87 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1D58 | 0.87 | |
DM6 | 4'-EPIDOXORUBICIN | A | 1QDA | 0.87 | |
DM2 | DOXORUBICIN | A | 2DR6 | 0.87 | |
DM2 | DOXORUBICIN | A | 1P20 | 0.87 | |
DM2 | DOXORUBICIN | A | 1I1E | 0.87 | |
DM2 | DOXORUBICIN | A | 151D | 0.87 | |
DM2 | DOXORUBICIN | A | 1D12 | 0.87 | |
DM2 | DOXORUBICIN | A | 1DA9 | 0.87 | |
C40 | N-[(2R,4S,5S,7R)-4-AMINO-8-(BUTYLAMINO)- 5-HYDROXY-2,7-DIMETHYL-8-OXOOCTYL]- 2-(3-METHOXYPROPOXY)BENZAMIDE | A | 2V13 | 0.71 | |
NGM | NOGALAMYCIN | A,B,C,D | 258D | 0.82 | |
NGM | NOGALAMYCIN | A | 282D | 0.82 | |
NGM | NOGALAMYCIN | A,B | 224D | 0.82 | |
NGM | NOGALAMYCIN | A,B | 245D | 0.82 | |
NGM | NOGALAMYCIN | A,B | 1QCH | 0.82 | |
NGM | NOGALAMYCIN | A | 1D17 | 0.82 | |
NGM | NOGALAMYCIN | A,B | 1D21 | 0.82 | |
NGM | NOGALAMYCIN | A,B | 182D | 0.82 | |
AKY | A,B,C,D | 2IPI | 0.8 | ||
BNR | BIS-DAUNORUBICIN | B | 1AMD | 0.84 | |
CCI | CALICHEAMICIN GAMMA-1-I | B | 1QMS | 0.72 | |
EB4 | N,N',N''-[(3S,7S,11S)-2,6,10-trioxo- 1,5,9-trioxacyclododecane-3,7,11- triyl]tris(2,3-dihydroxybenzamide) | A,B,C | 3CMP | 0.71 | |
429 | 2-{4-[2-ACETYLAMINO-3-(4-CARBOXYMETHOXY- 3-HYDROXY-PHENYL)-PROPIONYLAMINO]- BUTOXY}-6-HYDROXY-BENZOIC ACID METHYL ESTER | A | 1QXK | 0.73 | |
DRA | 11-DEOXY-BETA-RHODOMYCIN | A,B | 1XDS | 0.81 | |
UMG | METHYL-UMBELLIFERTL-N-ACETYL-CHITOTRIOSE | A | 1BB6 | 0.73 | |
DVV | DESVANCOSAMINYL VANCOMYCIN | A,B | 1PN3 | 0.73 | |
DVV | DESVANCOSAMINYL VANCOMYCIN | A,B | 1RRV | 0.73 | |
L01 | 3-[({(1S,2R)-1-BENZYL-2-HYDROXY- 3-[(3-METHOXYBENZYL)AMINO]PROPYL}AMINO)(HYDROXY)METHYL]- N,N-DIPROPYLBENZAMIDE | A | 1W51 | 0.71 | |
CCG | CALICHEAMICIN GAMMA-1 | A | 2GKC | 0.72 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D36 | 0.85 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1R68 | 0.85 | |
MAR | 4'-EPI-4'-(2-DEOXYFUCOSE)DAUNOMYCIN | A | 1D35 | 0.85 | |
BMY | BALHIMYCIN | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,S | 1GO6 | 0.72 | |
BMY | BALHIMYCIN | A,B,C,D,E,M | 1HHU | 0.72 | |
A32 | (3-NITRO-5-(3-MORPHOLIN-4-YL-PROPYLAMINOCARBONYL)PHENYL)- GALACTOPYRANOSIDE | D,E,F,G,H,L, M,O,P,V,W,X, Y,Z | 1JQY | 0.71 | |
GUM | 4-METHYL-UMBELLIFERYL-N-ACETYL- CHITOBIOSE | A | 1BB7 | 0.73 | |
A24 | (3-NITRO-5-(2-MORPHOLIN-4-YL-ETHYLAMINOCARBONYL)PHENYL)- GALACTOPYRANOSIDE | D,E,F,G,H | 1JR0 | 0.71 | |
INX | 2-(CARBOXYMETHOXY)-5-[(2S)-2-({(2S)- 2-[(3-CARBOXYPROPANOYL)AMINO] - 3-PHENYLPROPANOYL}AMINO)-3-OXO- 3-(PENTYLAMINO)PROPYL]BENZOIC ACID | A | 1G7G | 0.73 | |
545 | [2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL- PIPERIDIN-2-YL)- ACETIC ACID BUTYL ESTER | A | 1JIK | 0.71 | |
PCY | PACTAMYCIN | A,D,H,N | 1HNX | 0.7 | |
HEH | HEDAMYCIN | A | 1JHI | 0.8 | |
NOV | NOVOBIOCIN | A,B | 1KIJ | 0.74 | |
NOV | NOVOBIOCIN | A,B | 1S14 | 0.74 | |
NOV | NOVOBIOCIN | A | 1AJ6 | 0.74 | |
EH5 | N-(1-BENZYL-3-{[3-(1,3-DIOXO-1,3- DIHYDRO-ISOINDOL-2-YL)-PROPIONYL]- [2-(HEXAHYDRO-BENZO[1,3]DIOXOL- 5-YL)-ETHYL]-AMINO}-2-HYDROXY-PROPYL)- 4-BENZYLOXY-3,5-DIMETHOXY-BENZAMIDE | A | 1LF3 | 0.74 | |
1DM | N-(2-MORPHOLIN-4-YL-1-MORPHOLIN- 4-YLMETHYL-ETHYL)-3-NITRO-5-(3,4,5- TRIHYDROXY-6-HYDROXYMETHYL-TETRAHYDRO- PYRAN-2-YLOXY)-BENZAMIDE | D,E,F,G,H | 1PZI | 0.7 | |
DM5 | IDARUBICIN | A,B,D | 198D | 0.84 | |
DM5 | IDARUBICIN | A | 1D38 | 0.84 | |
DM5 | IDARUBICIN | A | 1D67 | 0.84 | |
NCS | B | 1KVH | 0.75 | ||
NCS | A | 2NEO | 0.75 | ||
TBH | 5-(2-{2-[(TERT-BUTOXY-HYDROXY-METHYL)- AMINO]-1-HYDROXY-3-PHENYL-PROPYLAMINO}- 3-HYDROXY-3-PENTYLAMINO-PROPYL)- 2-CARBOXYMETHOXY-BENZOIC ACID | B | 1JF7 | 0.73 | |
DM7 | 4'-DEOXY-4'-IODODOXORUBICIN | A | 1IMR | 0.83 | |
DM7 | 4'-DEOXY-4'-IODODOXORUBICIN | A | 1IMS | 0.83 | |
CMD | 3'-DESAMINO-3'-(3-CYANO-4-MORPHOLINYL)- DOXORUBICIN | A | 236D | 0.84 | |
MR0 | N~3~-{(1S,2R)-1-(3,5-DIFLUOROBENZYL)- 2-HYDROXY-3-[(3-METHOXYBENZYL)AMINO]PROPYL}- N~1~,N~1~-DIPROPYLBENZENE-1,3,5- TRICARBOXAMIDE | A,B,C | 2P83 | 0.72 | |
DM3 | 6-DEOXYDAUNOMYCIN | A | 1D14 | 0.86 | |
NGU | U-58872, HYDROXY DERIVATIVE OF NOGALAMYCIN | A,B | 1D22 | 0.82 | |
VAN | VANCOMYCIN | A | 1C0R | 0.72 | |
VAN | VANCOMYCIN | A,B | 1SHO | 0.72 | |
VAN | VANCOMYCIN | A,B | 1PNV | 0.72 | |
VAN | VANCOMYCIN | A | 1C0Q | 0.72 | |
VAN | VANCOMYCIN | A | 1QD8 | 0.72 | |
VAN | VANCOMYCIN | A,B,C,D,E,F | 1FVM | 0.72 | |
VAN | VANCOMYCIN | A | 1AA5 | 0.72 | |
BDA | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AL9 | 0.86 | |
BDA | 4-METHYLBENZYL-N-BIS[DAUNOMYCIN] | A | 1AGL | 0.86 | |
AKT | 10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT) | A | 1Q0R | 0.84 | |
AI1 | N-BENZYL-3-(ALPHA-D-GALACTOS-1- YL)-BENZAMIDE | D,E,F,G,H,L, M,N,O,P | 1FD7 | 0.75 | |
S2A | A | 2OEY | 0.76 | ||
BA1 | BALANOL | A | 1BX6 | 0.77 |